Oseltamivir Placebo

DRUG2 trials

Sponsors

Capital Medical University, Joincare Pharmaceutical Group Industry Co., Ltd

Conditions

InfluenzaRespiratory Viral Infection

Phase 3

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

RecruitingNCT07236814

Capital Medical UniversityInfluenza

Start: 2025-11-28End: 2027-03-06Target: 384Updated: 2026-03-23

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

RecruitingNCT07357051

Joincare Pharmaceutical Group Industry Co., LtdRespiratory Viral Infection

Start: 2025-11-07End: 2026-04-15Target: 177Updated: 2026-01-21